Incorporating the Patient Perspective Into Your HIV Treatment Plan

Released On
December 20, 2019

Expires On
December 20, 2020

Media Type
Internet

Completion Time
60 minutes

Specialty
Case Management, Infectious Disease, Occupational Medicine

Topic(s)
HIV

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC.

 

Supported by an educational grant from ViiV Healthcare.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1 Contact Hours.

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for HIV specialists, as well as physician assistants and nurse practitioners. Primary care physicians and pharmacists will also be invited to participate.

Program Overview

The advent of antiretroviral therapy (ART), has granted the possibility of controlling the HIV epidemic. Adherence to ART helps maintain a low/undetectable viral load under control and prolong the time of progression to AIDS, resulting in near normal life expectancy. The availability of highly active antiretroviral therapy has provided tremendous breakthroughs such as suppression of virus replication and restoration of immunity in infected persons. HIV management requires life-long treatment, therefore some of the major obstacles physicians face with ART is the incidence of adverse effects of the treatment, pill burden and stigma, which persuade patients to discontinue the treatment. This activity is designed to update clinicians on the evolving landscape of treatment options in the management of HIV while incorporating the patient perspective into clinical decision making.

Learning Objectives

Upon completion of this activity, participants should be better prepared to:

  • Select first-line ART regimens utilizing key clinical considerations
  • Utilize clinical factors surrounding virologic failure in the selection of second-line ART in patients with HIV
  • Outline the impact of common comorbid conditions on selection of ART regimens in patients diagnosed with HIV
  • Identify barriers to HIV care, impact of HIV on health-related quality-of-life, and influence on patient adherence

Faculty

Eric S. Daar, MD

Chief, Division of HIV Medicine at Harbor-UCLA Medical Center
Professor of Medicine at David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, CA

Betty J. Dong, PharmD, FASHP, FAPHA, FCCP, AAHIVP

Professor of Clinical Pharmacy and Family and Community Medicine
Departments of Clinical Pharmacy and Family and Community Medicine,
Schools of Pharmacy and Medicine
University of California, San Francisco
San Francisco, CA

Jason Tokumoto (Patient Interviewee)

Physician Accreditation Statement

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians

Physician Credit Designation

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Disclosures of Conflicts of Interest

Eric S. Daar, MD

  • Grant/Research Support: Gilead Sciences, Inc.; Merck, ViiV; Consultant: Gilead Sciences, Inc.

Betty J. Dong, PharmD, FASHP, FAPHA, FCCP, AAHIVP

  • Other: American College of Clinical Pharmacy (ACCP); role as faculty panel chair in continuing education on HIV

The staff of Physicians' Education Resource®, LLC, (PER®) have no relevant financial relationships with commercial interests to disclose.

Method of Participation

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Videos” will be available for your reference.
  • In order to receive a CME certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME Certificate upon completion of these steps.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.